Patients with obesity have increased risk for CVD in part due to an atherogenic lipid profile, so reduction of weight, LDL and non-HDL should be a priority for them, a speaker said during the National Lipid Association Scientific Sessions.
Harold E. Bays, MD, DABOM, MFOMA, FTOS, FACC, FASPC, FNLA, the medical director and president of the Louisville Metabolic and Atherosclerosis Research Center and clinical associate professor at the University of Louisville School of Medicine, presented an overview of a joint expert review from the National Lipid Association and the Obesity Medicine